Registration Strip Icon for monitor Monitoree múltiples cotizaciones en tiempo real de los principales intercambios, como la Bolsa de Valores de Londres, NASDAQ, NYSE, AMEX, Bovespa y más.

PIRS

Pieris Pharmaceuticals (PIRS)

Pieris Pharmaceuticals Inc
Fecha:
Ordernar por:
 Showing the most relevant articles for your search:NASDAQ:PIRS
FechaHoraFuenteTítuloSímboloCompañía
15/05/202415:01Edgar (US Regulatory)Form 10-Q - Quarterly report [Sections 13 or 15(d)]NASDAQ:PIRSPieris Pharmaceuticals Inc
09/05/202407:00Edgar (US Regulatory)Form 8-K - Current reportNASDAQ:PIRSPieris Pharmaceuticals Inc
14/02/202415:37Edgar (US Regulatory)Form SC 13G/A - Statement of acquisition of beneficial ownership by individuals: [Amend]NASDAQ:PIRSPieris Pharmaceuticals Inc
31/08/202315:15Edgar (US Regulatory)Form 8-K/A - Current report: [Amend]NASDAQ:PIRSPieris Pharmaceuticals Inc
10/08/202316:04Edgar (US Regulatory)Form S-8 - Securities to be offered to employees in employee benefit plansNASDAQ:PIRSPieris Pharmaceuticals Inc
26/06/202316:26Edgar (US Regulatory)Current Report Filing (8-k)NASDAQ:PIRSPieris Pharmaceuticals Inc
23/06/202315:47Edgar (US Regulatory)Statement of Changes in Beneficial Ownership (4)NASDAQ:PIRSPieris Pharmaceuticals Inc
12/06/202305:43Edgar (US Regulatory)Statement of Ownership (sc 13g)NASDAQ:PIRSPieris Pharmaceuticals Inc
22/05/202316:01Edgar (US Regulatory)Initial Statement of Beneficial Ownership (3)NASDAQ:PIRSPieris Pharmaceuticals Inc
11/05/202305:02Edgar (US Regulatory)Quarterly Report (10-q)NASDAQ:PIRSPieris Pharmaceuticals Inc
28/04/202315:22Edgar (US Regulatory)Annual Report to Security Holders (ars)NASDAQ:PIRSPieris Pharmaceuticals Inc
28/04/202315:20Edgar (US Regulatory)Additional Proxy Soliciting Materials (definitive) (defa14a)NASDAQ:PIRSPieris Pharmaceuticals Inc
31/03/202315:05Edgar (US Regulatory)Annual Report (10-k)NASDAQ:PIRSPieris Pharmaceuticals Inc
14/02/202315:19Edgar (US Regulatory)Amended Statement of Ownership (sc 13g/a)NASDAQ:PIRSPieris Pharmaceuticals Inc
03/01/202315:56Edgar (US Regulatory)Confidential Treatment Order (ct Order)NASDAQ:PIRSPieris Pharmaceuticals Inc
04/11/202216:11Edgar (US Regulatory)Prospectus Filed Pursuant to Rule 424(b)(5) (424b5)NASDAQ:PIRSPieris Pharmaceuticals Inc
04/08/202216:06Edgar (US Regulatory)Securities Registration: Employee Benefit Plan (s-8)NASDAQ:PIRSPieris Pharmaceuticals Inc
12/05/202205:02Edgar (US Regulatory)Amended Current Report Filing (8-k/a)NASDAQ:PIRSPieris Pharmaceuticals Inc
29/04/202215:12Edgar (US Regulatory)Proxy Statement (definitive) (def 14a)NASDAQ:PIRSPieris Pharmaceuticals Inc
08/01/202208:15TipRanksAnalysts Offer Insights on Healthcare Companies: Neurocrine (NBIX), Pieris Pharmaceuticals (PIRS) and Biohaven Pharmaceutical Holding Co (BHVN)NASDAQ:PIRSPieris Pharmaceuticals Inc
16/08/202105:36Edgar (US Regulatory)Notice of Effectiveness (effect)NASDAQ:PIRSPieris Pharmaceuticals Inc
05/08/202115:49Edgar (US Regulatory)Securities Registration Statement (simplified Form) (s-3)NASDAQ:PIRSPieris Pharmaceuticals Inc
25/06/202105:18TipRanksWhat Makes Penny Stock Pieris Pharma A “Strong Buy”?NASDAQ:PIRSPieris Pharmaceuticals Inc
01/06/202115:02Edgar (US Regulatory)Prospectus Filed Pursuant to Rule 424(b)(3) (424b3)NASDAQ:PIRSPieris Pharmaceuticals Inc
26/05/202117:37TipRanksPieris: Shares Can Still Soar Much Higher, Says AnalystNASDAQ:PIRSPieris Pharmaceuticals Inc
25/06/202016:00Edgar (US Regulatory)Amended Statement of Changes in Beneficial Ownership (4/a)NASDAQ:PIRSPieris Pharmaceuticals Inc
20/11/201907:10Edgar (US Regulatory)Small Company Offering and Sale of Securities Without Registration (d)NASDAQ:PIRSPieris Pharmaceuticals Inc
08/11/201807:00GlobeNewswire Inc.Pieris Pharmaceuticals to Present at Investor Conferences in NovemberNASDAQ:PIRSPieris Pharmaceuticals Inc
07/11/201806:00GlobeNewswire Inc.Pieris Pharmaceuticals Reports Third Quarter 2018 Financial Results and Provides Corporate UpdateNASDAQ:PIRSPieris Pharmaceuticals Inc
31/10/201807:00GlobeNewswire Inc.Pieris Pharmaceuticals to Host Third Quarter 2018 Investor Call and Corporate Update on November 7, 2018NASDAQ:PIRSPieris Pharmaceuticals Inc
 Showing the most relevant articles for your search:NASDAQ:PIRS

Su Consulta Reciente

Delayed Upgrade Clock